These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 1771411

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Hirudin as alternative anticoagulant--a historical review.
    Markwardt F.
    Semin Thromb Hemost; 2002 Oct; 28(5):405-14. PubMed ID: 12420235
    [Abstract] [Full Text] [Related]

  • 23. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M, Mantz F, Nicolini P, Gachet C, Mulvihill J, Meyer L, Beretz A, Cazenave JP.
    Thromb Haemost; 1993 May 03; 69(5):515-21. PubMed ID: 8322274
    [Abstract] [Full Text] [Related]

  • 24. [R-hirudin (lepirudin, refludan) as an alternative anticoagulant in heparin-induced thrombocytopenia during cardiopulmonary bypass connection].
    Shah AC, Genoni M, Niederhäuser U, Maloigne M, Turina M.
    Schweiz Med Wochenschr; 2000 Jun 10; 130(23):896-9. PubMed ID: 10897491
    [Abstract] [Full Text] [Related]

  • 25. Subcutaneous recombinant hirudin (HBW 023) versus intravenous sodium heparin in treatment of established acute deep vein thrombosis of the legs: a multicentre prospective dose-ranging randomized trial. International Multicentre Hirudin Study Group.
    Schiele F, Lindgaerde F, Eriksson H, Bassand JP, Wallmark A, Hansson PO, Grollier G, Sjo M, Moia M, Camez A, Smyth V, Walker M.
    Thromb Haemost; 1997 May 10; 77(5):834-8. PubMed ID: 9184388
    [Abstract] [Full Text] [Related]

  • 26. [Systemic effects of thrombolytic therapy].
    Balduini CL, Gamba G, Bertolino G, Noris P, Previtali M, Ascari E.
    Haematologica; 1991 Jun 10; 76 Suppl 3():281-90. PubMed ID: 1752524
    [No Abstract] [Full Text] [Related]

  • 27. Experimental studies on a recombinant hirudin, CGP 39393.
    Gray E, Watton J, Cesmeli S, Barrowcliffe TW, Thomas DP.
    Thromb Haemost; 1991 Apr 08; 65(4):355-9. PubMed ID: 2057916
    [Abstract] [Full Text] [Related]

  • 28. Experimental and clinical pharmacology of pentosan polysulfate.
    Maffrand JP, Herbert JM, Bernat A, Defreyn G, Delebassee D, Savi P, Pinot JJ, Sampol J.
    Semin Thromb Hemost; 1991 Apr 08; 17 Suppl 2():186-98. PubMed ID: 1719639
    [No Abstract] [Full Text] [Related]

  • 29. Recombinant factor VIIa in multiple surgery.
    Schulman S, Lindstedt M, Alberts KA, Agren PH.
    Thromb Haemost; 1994 Jan 08; 71(1):154. PubMed ID: 8165636
    [No Abstract] [Full Text] [Related]

  • 30. Hirudin and platelets.
    Glusa E.
    Semin Thromb Hemost; 1991 Apr 08; 17(2):122-5. PubMed ID: 1771409
    [No Abstract] [Full Text] [Related]

  • 31. Pharmacological studies on the antithrombotic action of hirudin in experimental animals.
    Markwardt F, Hauptmann J, Nowak G, Klessen C, Walsmann P.
    Thromb Haemost; 1982 Jun 28; 47(3):226-9. PubMed ID: 7112494
    [Abstract] [Full Text] [Related]

  • 32. Limitations of the laboratory monitoring of heparin therapy. Scientific and Standardization Committee Communications: on behalf of the Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Greaves M, Control of Anticoagulation Subcommittee of the Scientific and Standardization Committee of the International Society of Thrombosis and Haemostasis.
    Thromb Haemost; 2002 Jan 28; 87(1):163-4. PubMed ID: 11848446
    [No Abstract] [Full Text] [Related]

  • 33. Recombinant desulfatohirudin as a substitute for heparin during cardiopulmonary bypass.
    Bernabei A, Rao AK, Niewiarowski S, Colman RW, Sun L, Edmunds LH.
    J Thorac Cardiovasc Surg; 1994 Aug 28; 108(2):381-2. PubMed ID: 8041187
    [No Abstract] [Full Text] [Related]

  • 34. Antithrombotic effect of tissue factor inhibition by inactivated factor VIIa: an ex vivo human study.
    Lev EI, Marmur JD, Zdravkovic M, Osende JI, Robbins J, Delfin JA, Richard M, Erhardtsen E, Thomsen MS, Lincoff AM, Badimon JJ.
    Arterioscler Thromb Vasc Biol; 2002 Jun 01; 22(6):1036-41. PubMed ID: 12067917
    [Abstract] [Full Text] [Related]

  • 35. Thrombin inhibitors in acute coronary artery disease.
    Vorchheimer DA, Fuster V.
    Eur Heart J; 2002 Aug 01; 23(15):1142-4. PubMed ID: 12127916
    [No Abstract] [Full Text] [Related]

  • 36. Stroke risk with higher heparin, hirudin dosages halts studies.
    Am J Health Syst Pharm; 1995 Jan 01; 52(1):8, 10. PubMed ID: 12879517
    [No Abstract] [Full Text] [Related]

  • 37. Report on a discussion forum: "Medical and surgical application of recombinant hirudin".
    Walenga JM, Markwardt F, Breddin K, Fareed J.
    Semin Thromb Hemost; 1991 Apr 01; 17(2):150-6. PubMed ID: 1771413
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Hirudin in haemodialysis.
    Bucha E, Markwardt F, Nowak G.
    Thromb Res; 1990 Dec 15; 60(6):445-55. PubMed ID: 2082478
    [Abstract] [Full Text] [Related]

  • 40. [Desirudine (Revasc): preventive therapy for deep venous thrombosis].
    Andréjak M.
    Presse Med; 1999 Nov 13; 28(35):1941-2. PubMed ID: 10598155
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.